Targeting LASP1, eIF4A1, e1F4B and CXCR4 with modulators and combinations thereof for cancer therapy Patent (Faculty180)

cited authors

  • Raman, D; Howard, C; Nemunitis, J; Brunicardi, F C; Liu, S H; Tiwari, Amit K

publication date

  • 2019

patent number

  • D-2019-32 62/807,075